IRIS Accounts Production v23.3.0.418 12327213 director 1.12.21 30.11.22 30.11.22 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh123272132021-11-30123272132022-11-30123272132021-12-012022-11-30123272132020-11-30123272132020-12-012021-11-30123272132021-11-3012327213ns10:Originalns15:EnglandWales2021-12-012022-11-3012327213ns14:PoundSterlingns10:Original2021-12-012022-11-3012327213ns10:Originalns10:Director12021-12-012022-11-3012327213ns10:Original2021-12-012022-11-3012327213ns10:Original2022-11-3012327213ns10:Originalns10:PrivateLimitedCompanyLtd2021-12-012022-11-3012327213ns10:Originalns10:SmallEntities2021-12-012022-11-3012327213ns10:Originalns10:AuditExempt-NoAccountantsReport2021-12-012022-11-3012327213ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2021-12-012022-11-3012327213ns10:SmallCompaniesRegimeForAccountsns10:Original2021-12-012022-11-3012327213ns10:Originalns10:FullAccounts2021-12-012022-11-3012327213ns10:Originalns10:RegisteredOffice2021-12-012022-11-3012327213ns10:Original2021-11-3012327213ns10:Originalns5:CurrentFinancialInstruments2022-11-3012327213ns10:Originalns5:CurrentFinancialInstruments2021-11-3012327213ns10:Originalns5:Non-currentFinancialInstruments2022-11-3012327213ns10:Originalns5:Non-currentFinancialInstruments2021-11-3012327213ns5:ShareCapitalns10:Original2022-11-3012327213ns5:ShareCapitalns10:Original2021-11-3012327213ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-11-3012327213ns10:Originalns5:RetainedEarningsAccumulatedLosses2021-11-3012327213ns10:Original2020-12-012021-11-3012327213ns10:Originalns5:PlantMachinery2021-11-3012327213ns10:Originalns5:PlantMachinery2021-12-012022-11-3012327213ns10:Originalns5:PlantMachinery2022-11-3012327213ns10:Originalns5:PlantMachinery2021-11-3012327213ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-11-3012327213ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2021-11-3012327213ns10:Originalns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2022-11-3012327213ns10:Originalns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2021-11-3012327213ns10:Originalns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2022-11-3012327213ns10:Originalns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2021-11-3012327213ns10:Original1ns10:Director12021-11-3012327213ns10:Original1ns10:Director12020-11-3012327213ns10:Original1ns10:Director12021-12-012022-11-3012327213ns10:Original1ns10:Director12020-12-012021-11-3012327213ns10:Original1ns10:Director12022-11-3012327213ns10:Original1ns10:Director12021-11-30
REGISTERED NUMBER: 12327213 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2022

FOR

THE SANCTUM MEDICAL AESTHETICS LIMITED

THE SANCTUM MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 12327213)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2022




Page

Company Information 1

Balance Sheet 2 to 3

Notes to the Financial Statements 4 to 6


THE SANCTUM MEDICAL AESTHETICS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 NOVEMBER 2022







DIRECTOR: Mrs K N Huggins





REGISTERED OFFICE: 149 King Street
Cottingham
E. Yorks
HU16 5QQ





REGISTERED NUMBER: 12327213 (England and Wales)





ACCOUNTANTS: Majors Limited
F15 The Bloc
38 Springfield Way
Anlaby
Hull
E. Yorks
HU10 6RJ

THE SANCTUM MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 12327213)

BALANCE SHEET
30 NOVEMBER 2022

2022 2021
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 6,075 8,220

CURRENT ASSETS
Stocks 1,987 -
Debtors 5 85,973 48,246
Cash at bank 3,767 7,765
91,727 56,011
CREDITORS
Amounts falling due within one year 6 59,918 73,091
NET CURRENT ASSETS/(LIABILITIES) 31,809 (17,080 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

37,884

(8,860

)

CREDITORS
Amounts falling due after more than
one year

7

54,192

22,416
NET LIABILITIES (16,308 ) (31,276 )

CAPITAL AND RESERVES
Called up share capital 50 50
Retained earnings (16,358 ) (31,326 )
SHAREHOLDERS' FUNDS (16,308 ) (31,276 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

THE SANCTUM MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 12327213)

BALANCE SHEET - continued
30 NOVEMBER 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 24 November 2023 and were signed by:





Mrs K N Huggins - Director


THE SANCTUM MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 12327213)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2022

1. STATUTORY INFORMATION

THE SANCTUM MEDICAL AESTHETICS LIMITED is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

THE SANCTUM MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 12327213)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2022

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2021 - 4 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 December 2021 9,265
Additions 1,124
At 30 November 2022 10,389
DEPRECIATION
At 1 December 2021 1,045
Charge for year 3,269
At 30 November 2022 4,314
NET BOOK VALUE
At 30 November 2022 6,075
At 30 November 2021 8,220

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Other debtors 32,025 32,025
Directors' current accounts 28,992 8,530
VAT 20,980 1,497
Prepayments and accrued income 3,976 6,194
85,973 48,246

THE SANCTUM MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 12327213)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2022

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Bank loans and overdrafts 15,900 6,389
Trade creditors 40,560 57,018
Social security and other taxes 2,463 4,998
Other creditors - 3,691
Accrued expenses 995 995
59,918 73,091

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
2022 2021
£    £   
Bank loans - 1-2 years 15,900 6,389
Bank loans - 2-5 years 38,292 16,027
54,192 22,416

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 November 2022 and 30 November 2021:

2022 2021
£    £   
Mrs K N Huggins
Balance outstanding at start of year 8,530 2,828
Amounts advanced 60,152 32,410
Amounts repaid (39,690 ) (26,708 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 28,992 8,530